Tag Archives: MD/PhD

4 Comments

Mark Speechley is a Professor of Epidemiology at Western University

 

The age-old debate over who should be addressed as ‘doctor’ lives again in recent letters to CMAJ. Of course, it is important not to confuse the public. Since more people get sick than get university educated, members of the public are more likely to have met a physician-doctor than a professor-doctor. As a PhD epidemiologist, ‘the population is my patient’. Consequently, when I meet my medical colleagues in the hospital, I do not expect to be addressed as ‘Doctor’, but should the whole population be in the hospital, and the crowding in the corridors be so acute that I would have the statistical power to practice my profession by expertly assembling the massed throngs of gurneys into long rows of cases and controls, or exposed and unexposed, as appropriate, I would most certainly expect to be addressed as such.  ...continue reading

charlesyinCharles Yin in a MD/PhD Candidate at the Schulich School of Medicine and Dentistry at Western University

 

On June 18, 2015 the Canadian Institutes of Health Research (CIHR) announced that it would be withdrawing funding support for the nation’s 14 MD/PhD programs by the 2016/2017 academic year. This announcement caught program directors and trainees across the country by surprise, and was at odds with the recommendations of two advisory panels commissioned by the CIHR, both of which identified a particular need to improve upon how clinician scientist training in Canada. Although the cutting of the CIHR funding was a blow to MD/PhD programs across the country, it looks like these programs won’t be shutting their doors for the foreseeable future. Rather, this development provides us as clinician scientists, physicians, researchers and policy makers with an opportunity ...continue reading